Agonistic and antagonistic activities of RU486 on the functions of the human progesterone receptor - PubMed (original) (raw)
Agonistic and antagonistic activities of RU486 on the functions of the human progesterone receptor
M E Meyer et al. EMBO J. 1990 Dec.
Abstract
RU486 induced the binding to a palindromic progestin responsive element (PRE) in vitro of homo- and heterodimers of the human progesterone receptor (hPR) isoforms A and B, present in T47D breast cancer cells or in HeLa cells transiently expressing the recombinant proteins. The resulting complexes were indistinguishable from those induced with the agonist R5020 with respect to specificity, affinity and stability. Ligand exposure was a necessary prerequisite to observe PR/PRE complexes. Antagonist-induced complexes migrated more rapidly during electrophoresis than agonist-induced ones, and no 'mixed' PR/RU486-PR/R5020 complexes were observed, suggesting that the dimerization interfaces of agonist- and antagonist-bound molecules are non-compatible. The analysis of a series of deletion mutants and chimeric receptors revealed the presence of two transcription activation functions (TAFs), located in the N-terminal region A/B (TAF-1) and the hormone binding domain (TAF-2). In the presence of agonists, both TAFs were active in HeLa cells. In the presence of RU486 TAF-2 was inactive, while TAF-1 within the hPR form B/RU486 complex activated transcription from a reporter gene containing a single palindromic PRE. We consider this to be the most convincing evidence that the receptor/RU486-complex does in fact bind to PREs in vivo. No transcriptional activation was observed in the presence of RU486 from a reporter gene containing the complex MMTV-LTR PRE. In contrast to hPR form B, form A was not able to activate transcription from PRE/GRE-tk-CAT in the presence of RU486. In vivo competition between hPR/RU486 and either cPR/R5020 or the human glucocorticoid receptor/dexamethasone (hGR/Dex) complex further supported that hPR/RU486 bound in vivo to its cognate responsive element. Indeed, the observed inhibition of transcription was shown to be due to competition for the MMTV PRE, since no transcriptional interference by the hPR/RU486 was observed, and since no heterodimers were formed between hPR/RU486 and cPR/R5020 or hGR/Dex. That the ligand-free hPR, however, was unable to compete, demonstrated that ligand binding is the prerequisite for DNA binding of hPR in vivo.
Similar articles
- The mechanism of RU486 antagonism is dependent on the conformation of the carboxy-terminal tail of the human progesterone receptor.
Vegeto E, Allan GF, Schrader WT, Tsai MJ, McDonnell DP, O'Malley BW. Vegeto E, et al. Cell. 1992 May 15;69(4):703-13. doi: 10.1016/0092-8674(92)90234-4. Cell. 1992. PMID: 1586949 - Agonist and antagonists induce homodimerization and mixed ligand heterodimerization of human progesterone receptors in vivo by a mammalian two-hybrid assay.
Leonhardt SA, Altmann M, Edwards DP. Leonhardt SA, et al. Mol Endocrinol. 1998 Dec;12(12):1914-30. doi: 10.1210/mend.12.12.0210. Mol Endocrinol. 1998. PMID: 9849965 - Antagonist-occupied human progesterone B-receptors activate transcription without binding to progesterone response elements and are dominantly inhibited by A-receptors.
Tung L, Mohamed MK, Hoeffler JP, Takimoto GS, Horwitz KB. Tung L, et al. Mol Endocrinol. 1993 Oct;7(10):1256-65. doi: 10.1210/mend.7.10.8123133. Mol Endocrinol. 1993. PMID: 8123133 - Progestin receptors: isoforms and antihormone action.
Gronemeyer H, Meyer ME, Bocquel MT, Kastner P, Turcotte B, Chambon P. Gronemeyer H, et al. J Steroid Biochem Mol Biol. 1991;40(1-3):271-8. doi: 10.1016/0960-0760(91)90192-8. J Steroid Biochem Mol Biol. 1991. PMID: 1958531 Review. - The A and B isoforms of the human progesterone receptor: two functionally different transcription factors encoded by a single gene.
Giangrande PH, McDonnell DP. Giangrande PH, et al. Recent Prog Horm Res. 1999;54:291-313; discussion 313-4. Recent Prog Horm Res. 1999. PMID: 10548881 Review.
Cited by
- Coactivator/corepressor ratios modulate PR-mediated transcription by the selective receptor modulator RU486.
Liu Z, Auboeuf D, Wong J, Chen JD, Tsai SY, Tsai MJ, O'Malley BW. Liu Z, et al. Proc Natl Acad Sci U S A. 2002 Jun 11;99(12):7940-4. doi: 10.1073/pnas.122225699. Epub 2002 Jun 4. Proc Natl Acad Sci U S A. 2002. PMID: 12048256 Free PMC article. - Jun dimerization protein 2 functions as a progesterone receptor N-terminal domain coactivator.
Wardell SE, Boonyaratanakornkit V, Adelman JS, Aronheim A, Edwards DP. Wardell SE, et al. Mol Cell Biol. 2002 Aug;22(15):5451-66. doi: 10.1128/MCB.22.15.5451-5466.2002. Mol Cell Biol. 2002. PMID: 12101239 Free PMC article. - Progesterone-Related Immune Modulation of Pregnancy and Labor.
Shah NM, Lai PF, Imami N, Johnson MR. Shah NM, et al. Front Endocrinol (Lausanne). 2019 Mar 29;10:198. doi: 10.3389/fendo.2019.00198. eCollection 2019. Front Endocrinol (Lausanne). 2019. PMID: 30984115 Free PMC article. Review. - Expression of insulin-like growth factor binding proteins by T-47D human breast cancer cells: regulation by progestins and antiestrogens.
Coutts A, Murphy LJ, Murphy LC. Coutts A, et al. Breast Cancer Res Treat. 1994;32(2):153-64. doi: 10.1007/BF00665766. Breast Cancer Res Treat. 1994. PMID: 7532465 - New aspects of progesterone interactions with the actin cytoskeleton and neurosteroidogenesis in the cerebellum and the neuronal growth cone.
Wessel L, Olbrich L, Brand-Saberi B, Theiss C. Wessel L, et al. J Histochem Cytochem. 2014 Dec;62(12):835-45. doi: 10.1369/0022155414550691. Epub 2014 Aug 20. J Histochem Cytochem. 2014. PMID: 25141866 Free PMC article. Review.
References
- Science. 1988 May 13;240(4854):889-95 - PubMed
- EMBO J. 1987 Dec 20;6(13):3985-94 - PubMed
- Cell. 1988 Jul 15;54(2):199-207 - PubMed
- Science. 1988 Aug 12;241(4867):812-6 - PubMed
- Nature. 1988 Aug 25;334(6184):721-4 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous